![Long-Acting Injectable Risperidone: An Emerging Tool in Schizophrenia Treatment | Journal of Psychosocial Nursing and Mental Health Services Long-Acting Injectable Risperidone: An Emerging Tool in Schizophrenia Treatment | Journal of Psychosocial Nursing and Mental Health Services](https://journals.healio.com/cms/asset/b4fec65e-586a-4560-ac16-3281762911a2/10.3928_02793695-20051201-04-table2.jpg)
Long-Acting Injectable Risperidone: An Emerging Tool in Schizophrenia Treatment | Journal of Psychosocial Nursing and Mental Health Services
![Short-term Effects of Risperidone Monotherapy on Spontaneous Brain Activity in First-episode Treatment-naïve Schizophrenia Patients: A Longitudinal fMRI Study | Scientific Reports Short-term Effects of Risperidone Monotherapy on Spontaneous Brain Activity in First-episode Treatment-naïve Schizophrenia Patients: A Longitudinal fMRI Study | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep34287/MediaObjects/41598_2016_Article_BFsrep34287_Fig1_HTML.jpg)
Short-term Effects of Risperidone Monotherapy on Spontaneous Brain Activity in First-episode Treatment-naïve Schizophrenia Patients: A Longitudinal fMRI Study | Scientific Reports
![Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study - ScienceDirect Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0920996421004515-gr2.jpg)
Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study - ScienceDirect
![Efficacy and Tolerability of Olanzapine, Quetiapine, and Risperidone in the Treatment of Early Psychosis: A Randomized, Double-Blind 52-Week Comparison | American Journal of Psychiatry Efficacy and Tolerability of Olanzapine, Quetiapine, and Risperidone in the Treatment of Early Psychosis: A Randomized, Double-Blind 52-Week Comparison | American Journal of Psychiatry](https://ajp.psychiatryonline.org/cms/10.1176/ajp.2007.164.7.1050/asset/images/medium/r915f1.jpeg)